|
|
Volumn 62, Issue 1, 2012, Pages 3-4
|
|
Oxaliplatin in the adjuvant treatment of colon cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CAPECITABINE;
FLUOROURACIL;
FOLINIC ACID;
OXALIPLATIN;
AGE DISTRIBUTION;
CANCER ADJUVANT THERAPY;
CANCER STAGING;
COLON CANCER;
COLORECTAL CANCER;
DISEASE FREE SURVIVAL;
DRUG CHOICE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
EVIDENCE BASED MEDICINE;
FRAIL ELDERLY;
HEALTH STATUS;
HIGH RISK POPULATION;
HUMAN;
MEDICAL DECISION MAKING;
MOLECULAR GENETICS;
MULTICENTER STUDY (TOPIC);
MULTIPLE CYCLE TREATMENT;
OUTCOME ASSESSMENT;
OVERALL SURVIVAL;
PATIENT SELECTION;
PERSONALIZED MEDICINE;
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
REVIEW;
RISK BENEFIT ANALYSIS;
RISK REDUCTION;
SURVIVAL TIME;
TREATMENT DURATION;
TREATMENT INDICATION;
UNITED STATES;
UNSPECIFIED SIDE EFFECT;
AGED;
ANTINEOPLASTIC AGENTS;
CHEMOTHERAPY, ADJUVANT;
COLONIC NEOPLASMS;
FEMALE;
HUMANS;
MALE;
NEOPLASM STAGING;
ORGANOPLATINUM COMPOUNDS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
TREATMENT OUTCOME;
|
|
EID: 84855797281
PISSN: 00079235
EISSN: 15424863
Source Type: Journal
DOI: 10.3322/caac.21131 Document Type: Review |
|
Times cited : (9)
|
|
References (0)
|
